News

The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid. The FDA ...
The Food and Drug Administration as approved the first generic of a drug used to treat severe hypoglycemia. The agency has approved a generic glucagon for injection, 1 mg, from Amphastar ...
Lupin has received approval from the Food and Drug Administration for liraglutide injection single-patient-use prefilled pens and glucagon for injection vials. Both of these products will be ...
Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The first generic GLP-1 receptor agonist in the U.S. has ...
Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs such as Wegovy and Zepbound.
SILVER SPRING, Md., Dec. 28, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the ...
For more information about uses for glucagon injections, talk with your doctor or pharmacist. As with all medications, the cost of glucagon injections can vary. Factors that may affect the price ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the first generic glucagon for injection, commonly used to treat severe hypoglycemia in ...
(HealthDay News) — The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist ...
Scott McDonald is a Newsweek deputy night editor based in Cape Coral, Florida. His focus is assigning and writing stories across all topics, from news to politics, business, weather, sports and ...